Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tonga Tech Press.
Press releases published on August 8, 2025
Capricor Therapeutics Announces Type A Meeting Scheduled with U.S. FDA
GlobeNewswire
·
August 8, 2025
SAN DIEGO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that a Type A meeting with the U.S. …
Fusemachines Appoints Christine Chambers, Experienced Public Company CFO, as Chief Financial Officer
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Fusemachines, Inc. (“Fusemachines” or the “Company”), a leading provider of enterprise AI products and services, today announced the appointment of Christine Chambers as the Company’s new Chief Financial Officer …
SaverOne Signs Agreement with Sdot Dan Regional Council to Deploy SaverOne System in its School Bus Fleet
GlobeNewswire
·
August 8, 2025
Sdot Dan becomes the latest regional council in central Israel to implement the SaverOne System to protect school children Petah Tikvah, Israel, Aug. 08, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company …
Snail Games’ Subsidiary, Interactive Films, Unveils a New Relationship Simulation Game The Fame Game: Welcome to Hollywood
GlobeNewswire
·
August 8, 2025
CULVER CITY, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, officially announced The Fame Game: Welcome to …
Is it down? – NordVPN launches a page and service status checker based on user reports
GlobeNewswire
·
August 8, 2025
LONDON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- NordVPN, a global leader in cybersecurity and privacy solutions, unveiled a new feature called “Is it down?” checker, designed to help users quickly determine whether popular websites and services are experiencing …
DatChat Rebrands to Myseum, Inc. to Align with Primary Strategic Focus on Social Group Media Sharing and Content Preservation
GlobeNewswire
·
August 8, 2025
Myseum, Inc.’s common stock and Series A warrants to begin trading on Nasdaq under the new trading symbols "MYSE" and “MYSEW”, respectively, effective August 11, 2025 Social group media sharing platform upgrade will make it easier to share and preserve …
Trident Digital Tech Holdings (TDTH) Seeks Stablecoin Licenses Across Multiple African Markets to Drive Ripple USD (RLUSD) Adoption
GlobeNewswire
·
August 8, 2025
SINGAPORE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (NASDAQ: TDTH), a Singapore-based leader in digital transformation and Web 3.0 activation, today announced plans to pursue regulatory approvals for stablecoin operations across …
Assembly Biosciences Announces Pricing of $175 Million in Equity Financings
GlobeNewswire
·
August 8, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (“Assembly Bio”) (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced the pricing of an …
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 8, 2025
-- Completed patient enrollment in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED); topline data expected at the end of September 2025 -- -- Cash resources of $31.9 million as of June 30, 2025, expected to fund operations …
Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire
·
August 8, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying …
DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors
GlobeNewswire
·
August 8, 2025
NORWELL, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and …
Vaxart CEO Issues Letter to Stockholders
GlobeNewswire
·
August 8, 2025
- Management Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on September 4, 2025 - SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical- …
Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients
GlobeNewswire
·
August 8, 2025
TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, …
Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea
GlobeNewswire
·
August 8, 2025
MELBOURNE, Australia and NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage pharmaceutical company developing innovative combination therapies for prevalent medical conditions, today announced new patient- …
Junshi Biosciences Announces the Acceptance of the sNDA for Toripalimab as the 1st-line Treatment of HER2-expressing Urothelial Carcinoma
GlobeNewswire
·
August 8, 2025
SHANGHAI, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Study of Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 Showing Reductions in Viral Shedding Rate and Genital Lesion Rate in Recurrent Genital Herpes
GlobeNewswire
·
August 8, 2025
– 94% reduction in HSV-2 shedding rate and 98% reduction in high viral load shedding rate, both statistically significant, observed in cohort evaluating 350 mg weekly oral dose compared to placebo over 29-day evaluation period – – 94% reduction in genital …
Leanova UK offers Evidence-Based Weight Management in the United Kingdom market
GlobeNewswire
·
August 8, 2025
London, UK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Leanova, a Dutch-owned health supplement company has entered the United Kingdom with its core product, a plant-based weight loss supplement. Designed to help control appetite and metabolism and reduce fat …
Spectral Medical Announces Second Quarter and Provides Corporate Update
GlobeNewswire
·
August 8, 2025
Topline Tigris results expected to be released around mid-August 2025 TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and …
Akero Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 8, 2025
Published results from the 96-Week Phase 2b SYMMETRY trial in the New England Journal of Medicine Three presentations at the EASL Congress 2025 highlighted data demonstrating statistically significant reversal of compensated cirrhosis (F4) due to MASH and …
Draganfly to Host Shareholder Update Call on August 11, 2025
GlobeNewswire
·
August 8, 2025
Saskatoon, SK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A), an award-winning, industry-leading developer of drone solutions and systems, announced today that it will host a shareholder update call on Monday, August …